Post, F., Moyle, G., Stellbrink, H., Domingo, P., Podzamczer, D., Fisher, M., . . . Lim, M. (2011). Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.
Citação norma ChicagoPost, F., et al. Randomized Comparison of Renal Effects, Efficacy, and Safety with Once-daily Abacavir/lamivudine Versus Tenofovir/emtricitabine, Administered with Efavirenz, in Antiretroviral-naive, HIV-1-infected Adults: 48-week Results from the ASSERT Study. 2011.
Citação norma MLAPost, F., et al. Randomized Comparison of Renal Effects, Efficacy, and Safety with Once-daily Abacavir/lamivudine Versus Tenofovir/emtricitabine, Administered with Efavirenz, in Antiretroviral-naive, HIV-1-infected Adults: 48-week Results from the ASSERT Study. 2011.